Yahoo Finance1 个月
Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment
16 announced that the U.S. based FDA has approved their Optune Lua device for NSCLC metastatic cancer treatment. Optune Lua is a wearable device for which tumor-treating fields (TTFields ...
Novocure shares soar 33% as FDA approves lung cancer treatment
Investing.com -- Novocure Ltd (NASDAQ:NVCR) shares soared sharply after the announcement that the FDA had approved Optune Lua ...